CER Daily Newsfeed

Value Viewpoint: January 23, 2026

(1/23, Kimberly Westrich, LinkedIn) comments “Tufts-CEVR published survey results from 57 HEOR leaders at 44 US-based pharmaceutical companies about how current U.S. policy is shaping evidence needs and HEOR strategy. There are insights on IRA, PDABs, MFN policies, ICER, and HCEI, concluding with advice for the HEOR field: The IRA and PDABs create opportunities for HEOR; Embed HEOR earlier in clinical development; ICER assessments are informative but incomplete guides to value; Section 3037 offers opportunities to promote health care economic information but there is a need for HEOR leadership to highlight its value and drive its use.” Full

Surgery Beats Medical Therapy in Type 2 Diabetes, Regardless of Social Deprivation: Study

(1/23, Elana Gotkine, Medical Xpress) reports “For adults with type 2 diabetes (T2D), surgery is superior to medical therapy for reducing hemoglobin A1c (HbA1c) levels and achieving weight loss, regardless of social deprivation, according to a study published online Jan. 20 in the Annals of Internal Medicine.” Full

Video: Future Directions in EGFR-Mutated NSCLC: Data Needs and Evolving Pharmacist Roles

(1/26, Alia Lynch, PharmD, BCOP, Kevin Chen, PharmD, MS, BCOP, CPP, Pharmacy Times) “...Panelists will identify key evidence gaps for therapies currently in use, including questions around long-term outcomes, sequencing strategies, resistance mechanisms, and comparative effectiveness across treatment modalities. The conversation will also consider how pharmacists’ roles may expand over the next five years, from overseeing therapy selection and managing adverse events to supporting adherence, facilitating patient education, and integrating real-world evidence into clinical decision-making.” View Video

I’m a Doctor Who Knows Better — but I Switched to an Inferior Drug to Save Money

(1/23, Amy Caggiula, STAT) comments “...We are both providers and consumers, and we have the data, the stories, and the unique expertise to demand better. Inside our own institutions, we should require employee health plans that reflect our clinical values. We must insist that ‘value-based care’ start with value-based coverage, because the truth is undeniable; HDHPs are structurally incoherent, and physicians now live the same rationing harms we see in patients.” Full

Reengineering ACOs To Make Medicare Competitive

(1/26, Purva Rawal, Elizabeth Fowler, Health Affairs Forefront) comments “...Together, reforms to build the next generation of ACOs should make TM a comprehensive, sustainable, and competitive option for beneficiaries guided by three main objectives: 1) driving broader provider participation in ACOs, 2) increasing integration and coordination at the community level to deliver whole-person care, and 3) enabling competition and choice by ensuring a level playing field between TM and MA.” Full